Lv51
1020 积分 2023-04-15 加入
Albuminuria Responses to Dapagliflozin in Patients With Type 2 Diabetes
1小时前
已完结
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
2小时前
已完结
Early Efficacy and Safety of Finerenone on Type 2 Diabetes‐Related Chronic Kidney Disease: A Real‐World Observational Study in China
2小时前
已完结
Mechanisms of diabetic kidney disease and established and emerging treatments
2小时前
已完结
Clinical outcomes in patients with type 2 diabetes mellitus-related kidney disease: A Jordanian population cohort study
2天前
已完结
Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells
11天前
已完结
Long-term safety and efficacy of hydroxychloroquine in patients with IgA nephropathy: a single-center experience
11天前
已完结
Kidney organoids: a 3-dimensional tool to unmask permeability factors in primary and recurrent FSGS
1个月前
已完结
Insights into proliferative glomerulonephritis with monoclonal immunoglobulin deposits – is it really monoclonal or not?
1个月前
已完结
Imidazopyrimidine-based Pyruvate Kinase M2 Activator Halts Diabetic Nephropathy Progression via Modulating Epithelial-To-Mesenchymal Transition and Fibrosis
1个月前
已关闭
皖公网安备34019202002308
